Joseph Payne Net Worth & Insider Trades
Joseph Payne - President and CEO, Arcturus Therapeutics Holdings Inc
What is Joseph Payne's Net Worth?
The current estimated net worth of Arcturus Therapeutics Holdings Inc's President and CEO, Joseph Payne, is estimated to be about $28.73M . Joseph Payne owns about 1,475,097 units of Arcturus Therapeutics Holdings Inc common stock. In the last 3 years at Arcturus Therapeutics Holdings Inc, Joseph Payne has sold an estimated value of $0 worth.
What is Joseph Payne's Past Insider Trading?
Joseph Payne's largest purchase order was 5,000 units , worth over $56.1K on August 30, 2019. In total, Joseph Payne has made about 6 transactions over 3 years of their time at Arcturus Therapeutics Holdings Inc. Joseph Payne usually trades in June and February, with the busiest year in 2020. The most recent transaction was a purchase order of 1,000 units , worth over $31.69K on June 10, 2020.
Joseph Payne
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Joseph Payne's Salary in 2020?
As President and CEO of Arcturus Therapeutics Holdings Inc, Joseph Payne has a total base salary of $500,000 . Joseph Payne received compensation valued at about $12,861,500 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of a bonus of $450,000 , option awards of $11,911,500 , and
What is Joseph Payne's' Mailing Address?
- Mailing address is 10628 Science Center Drive Suite 200 San Diego CA 92121 CA
Arcturus Therapeutics Holdings Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Joseph E. Payne | 2020 | $500,000 | $450,000 | $11,911,500 | - | $12,861,500 |
| Joseph E. Payne | 2019 | $450,000 | $243,000 | $472,818 | - | $1,165,818 |
| Joseph E. Payne | 2018 | $425,000 | $372,532 | $636,888 | $1,252,624 | $2,687,044 |
| Dr. Padmanabh Chivukula | 2020 | $400,000 | $240,000 | $6,832,600 | - | $7,472,600 |
| Dr. Padmanabh Chivukula | 2019 | $370,000 | $133,200 | $132,956 | - | $636,156 |
| Dr. Padmanabh Chivukula | 2018 | $350,000 | $83,233 | $424,592 | $515,080 | $1,372,905 |
| Andy Sassine, | 2020 | $400,000 | $240,000 | $7,014,800 | - | $7,654,800 |
| Andy Sassine, | 2019 | $375,000 | $150,000 | $801,880 | - | $1,326,880 |
| Andy Sassine, | 2018 | $120,000 | - | $126,340 | - | $246,340 |
| Dr. Steven Hughes | 2020 | $415,000 | $249,000 | $4,212,625 | - | $4,876,625 |
| Dr. Steven Hughes | 2019 | $299,873 | - | - | - | $299,873 |
| Lance Kurata | 2020 | $156,250 | $67,500 | $4,916,800 | - | $5,140,550 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1768224/000119380521000583/e620530_def14a-arct.htm
What are Arcturus Therapeutics Holdings Inc's Past Insider Trades?
Arcturus Therapeutics Holdings Inc's most recent insider trade came on January 6, 2022 by Pad Chivukula who sold 8,100 units worth $324K . In the last 3 years, insiders at Arcturus Therapeutics Holdings Inc have sold an estimated value of $131.44M and bought an estimated value of $10.26M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Pad Chivukula, Chief Scientific Officer & COO, Andy Sassine, Chief Financial Officer, and Joseph Payne, President and CEO .
Arcturus Therapeutics Ltd. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||